Impact of vitamin D therapy on decreasing of proteinuria in type 2 diabetic patients

Background: Vitamin D (Vit D) deficiency is a common disorder in diabetic patients and may be a risk factor for ischemic heart disease and exacerbation of diabetic nephropathy(DN). Objectives: The aim of this study was to evaluate the effect of Vit D3 therapy on protein uriain type 2 diabetic patien...

Full description

Bibliographic Details
Main Authors: Ali Momeni, Mahmood Mirhosseini, Mohsen Kabiri, Soleiman Kheiri
Format: Article
Language:English
Published: Society of Diabetic Nephropathy Prevention 2017-01-01
Series:Journal of Nephropathology
Subjects:
Online Access:https://nephropathol.com/PDF/JNP-6-10.pdf
_version_ 1827948587740299264
author Ali Momeni
Mahmood Mirhosseini
Mohsen Kabiri
Soleiman Kheiri
author_facet Ali Momeni
Mahmood Mirhosseini
Mohsen Kabiri
Soleiman Kheiri
author_sort Ali Momeni
collection DOAJ
description Background: Vitamin D (Vit D) deficiency is a common disorder in diabetic patients and may be a risk factor for ischemic heart disease and exacerbation of diabetic nephropathy(DN). Objectives: The aim of this study was to evaluate the effect of Vit D3 therapy on protein uriain type 2 diabetic patients with deficient or insufficient serum Vit D. Patients and Methods: In a double blind clinical trial, 60 type 2 diabetic patients with proteinuria greater than 150 mg/day who had Vit D deficiency or insufficiency were randomly enrolled in two equal groups. Pearl of Vit D as 50 000 IU/week and placebo (1 tablet per week) were prescribed in patients of case and control groups respectively for 8 weeks. At the beginning and 2 months later, 24 hours urine protein was checked in all patients. Results: There is no difference between serums Vit D level in case and control group at the beginning of the study, however at the end of the study serum Vit D level was significantly higher in the case group. There is no difference in proteinuria between case and control group at the beginning and the end of the study, while a significant difference between the changes of proteinuria before and after the study was seen in two groups (P = 0.028). Conclusions: Vit D deficiency may exacerbate protein uric and DN, hence correction of Vit D deficiency may decrease proteinuria in diabetic patients with nephropathy.
first_indexed 2024-04-09T12:57:42Z
format Article
id doaj.art-f43cce48ada5460a89e2da79ffb0f3d5
institution Directory Open Access Journal
issn 2251-8363
2251-8819
language English
last_indexed 2024-04-09T12:57:42Z
publishDate 2017-01-01
publisher Society of Diabetic Nephropathy Prevention
record_format Article
series Journal of Nephropathology
spelling doaj.art-f43cce48ada5460a89e2da79ffb0f3d52023-05-13T11:31:52ZengSociety of Diabetic Nephropathy PreventionJournal of Nephropathology2251-83632251-88192017-01-0161101410.15171/jnp.2017.03JNP_20161009155930Impact of vitamin D therapy on decreasing of proteinuria in type 2 diabetic patientsAli Momeni0Mahmood Mirhosseini1Mohsen Kabiri2Soleiman Kheiri3Department of Internal Medicine, Shahrekord University of Medical Sciences, Shahrekord, IranDepartment of Internal Medicine, Shahrekord University of Medical Sciences, Shahrekord, IranDepartment of Internal Medicine, Shahrekord University of Medical Sciences, Shahrekord, IranSocial Health Determinants Research Center, Shahrekord University of Medical Sciences, Shahrekord, IranBackground: Vitamin D (Vit D) deficiency is a common disorder in diabetic patients and may be a risk factor for ischemic heart disease and exacerbation of diabetic nephropathy(DN). Objectives: The aim of this study was to evaluate the effect of Vit D3 therapy on protein uriain type 2 diabetic patients with deficient or insufficient serum Vit D. Patients and Methods: In a double blind clinical trial, 60 type 2 diabetic patients with proteinuria greater than 150 mg/day who had Vit D deficiency or insufficiency were randomly enrolled in two equal groups. Pearl of Vit D as 50 000 IU/week and placebo (1 tablet per week) were prescribed in patients of case and control groups respectively for 8 weeks. At the beginning and 2 months later, 24 hours urine protein was checked in all patients. Results: There is no difference between serums Vit D level in case and control group at the beginning of the study, however at the end of the study serum Vit D level was significantly higher in the case group. There is no difference in proteinuria between case and control group at the beginning and the end of the study, while a significant difference between the changes of proteinuria before and after the study was seen in two groups (P = 0.028). Conclusions: Vit D deficiency may exacerbate protein uric and DN, hence correction of Vit D deficiency may decrease proteinuria in diabetic patients with nephropathy.https://nephropathol.com/PDF/JNP-6-10.pdfvitamin ddiabetes mellitusproteinuriadiabetic nephropathy
spellingShingle Ali Momeni
Mahmood Mirhosseini
Mohsen Kabiri
Soleiman Kheiri
Impact of vitamin D therapy on decreasing of proteinuria in type 2 diabetic patients
Journal of Nephropathology
vitamin d
diabetes mellitus
proteinuria
diabetic nephropathy
title Impact of vitamin D therapy on decreasing of proteinuria in type 2 diabetic patients
title_full Impact of vitamin D therapy on decreasing of proteinuria in type 2 diabetic patients
title_fullStr Impact of vitamin D therapy on decreasing of proteinuria in type 2 diabetic patients
title_full_unstemmed Impact of vitamin D therapy on decreasing of proteinuria in type 2 diabetic patients
title_short Impact of vitamin D therapy on decreasing of proteinuria in type 2 diabetic patients
title_sort impact of vitamin d therapy on decreasing of proteinuria in type 2 diabetic patients
topic vitamin d
diabetes mellitus
proteinuria
diabetic nephropathy
url https://nephropathol.com/PDF/JNP-6-10.pdf
work_keys_str_mv AT alimomeni impactofvitamindtherapyondecreasingofproteinuriaintype2diabeticpatients
AT mahmoodmirhosseini impactofvitamindtherapyondecreasingofproteinuriaintype2diabeticpatients
AT mohsenkabiri impactofvitamindtherapyondecreasingofproteinuriaintype2diabeticpatients
AT soleimankheiri impactofvitamindtherapyondecreasingofproteinuriaintype2diabeticpatients